コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 p (sepsis) and one in the regorafenib group (intestinal perforation).
2 Its most feared complication is intestinal perforation.
3 migration into the pelvic region that caused intestinal perforation.
4 abdominal computed tomography confirmed the intestinal perforation.
5 in the peritoneal cavity does not confirm an intestinal perforation.
6 omplicated by toxic megacolon with impending intestinal perforation.
7 with intraoperative findings consistent with intestinal perforation.
8 was replicated in a neonatal mouse model of intestinal perforation.
9 nial ultrasound in preterm infants following intestinal perforations.
10 only hospital related factor associated with intestinal perforation after ERCP (OR: 1.56; 95% CI 1.28
11 in the abdominal area may result from either intestinal perforation after infection or after intestin
13 iation of opioid analgesia and sedation with intestinal perforation and failed reduction in children.
16 of death were lung infection in one patient, intestinal perforation and small intestinal obstruction
19 serious adverse events-febrile neutropenia, intestinal perforation, and cholangitis-were reported by
20 gery, necrotizing enterocolitis, spontaneous intestinal perforation, and neurodevelopmental outcomes-
21 ates of hypertension, thromboembolic events, intestinal perforation, and neutropenia in the bevacizum
22 both the invA- and lpfC-mediated pathways of intestinal perforation are conserved in mouse virulent S
23 r necrotizing enterocolitis (NEC)-associated intestinal perforations, are linked to lifelong neurolog
24 2.51, 95% CI 1.23-5.1), diagnosis of single intestinal perforation at laparotomy (aOR 3.1 95% CI 1.0
25 ubular foreign body density, compatible with intestinal perforation due to migration of the biliary s
28 rospective cohort of patients with confirmed intestinal perforation in 2016 and performed enhanced mi
29 s one treatment-related death in each group (intestinal perforation in the fruquintinib group and car
30 varied according to the presence/absence of intestinal perforation, intestinal matting and intestina
31 necrotizing enterocolitis (NEC) or isolated intestinal perforation (IP); 2) to determine the ability
34 stopathology, and radiology, the etiology of intestinal perforation is frequently assumed but rarely
35 ue to intra-abdominal pathologies, including intestinal perforation, ischemia, bowel obstruction, abs
43 nephritis, cardiac involvement, stroke, and intestinal perforation related to treatment with tociliz
45 ed for their development of NEC, spontaneous intestinal perforation (SIP), or other GI conditions and
46 atient and hospital factors for ERCP related intestinal perforation using a large national database.
47 to pembrolizumab occurred; one death due to intestinal perforation was attributed to chemotherapy.
49 for necrotizing enterocolitis or spontaneous intestinal perforation were significantly associated wit
50 wever, only 3, including one diagnosed after intestinal perforation, were diagnosed before the presen